Relafen 750, the novel compound of naproxen, offers the fascinating case from our biochemical pharmacy perspective. This mechanism of action, primarily involving inhibition of cyclooxygenase enzymes – COX-1 and COX-2 – leads to significant reduction in prostaglandin creation. Considering our biochemical context, the drug's potency is strongly a… Read More